Form D · Other Health Care

Neela Therapeutics, Inc.

Lunenburg, MA · CIK 0002090797

Offering snapshot reported May 26, 2026 · SEC filing

Reported sold
$13.8M
Offering amount: $21.5M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 14, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.91M$13.8MNov 24, 2025: $12,010,000.00Nov 24, 2025May 26, 2026: $13,821,643.00May 26, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$12,010,000 → $13,821,643
  • Reported investors17 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 26, 2026Amendment$13,821,643$1,811,643vs Nov 24, 202521SEC filing
Nov 24, 2025Initial$12,010,000No comparison17SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-564918

Source: Form D, filed May 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pj Anand Director, Executive
David Donabedian Director
Cameron Durrant Director
Edgar D. Jannotta Jr. Director
Stephen Oesterle Director
Norbert Riedel Director
Richard Upton Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
96 Robbs Hill Road
Lunenburg, MA, 01462